Ambroxol tablets 30 mg blister No. 20

Pharmacological properties

Mucolytic agent. Ambroxol hydrochloride normalizes impaired bronchopulmonary secretion, reduces sputum viscosity, facilitates the removal of sputum from the bronchi. The drug does not cause excessive secretion, is non-toxic, and is well tolerated.

After oral administration, the maximum concentration in blood plasma is reached after 2 hours. It is intensively metabolized in the liver. It is excreted mainly in the urine (90%).

Indication

Acute and chronic bronchitis of various etiologies, including those complicated by bronchiectasis, BA, pulmonary tuberculosis, pneumonia, inflammatory diseases of the nasopharynx. The drug can be used for respiratory failure syndrome ("shock lung"), for the prevention and treatment of complications after lung surgery, when caring for a tracheostomy, before and after bronchoscopy, and for cystic fibrosis.

Application

The tablets are taken after meals, with water.

Children over 12 years of age and adults are prescribed according to the following scheme: in the first 2-3 days, 1 tablet (30 mg) 3 times a day, then 1 tablet 2 times a day.

Children under 12 years of age are recommended to be prescribed the drug in a different dosage form. The course of treatment is 4-14 days.

Contraindication

Gastric and duodenal ulcer, I trimester of pregnancy, hypersensitivity to the drug; convulsions of any etiology.

Side effects

Ambroxol is well tolerated, but occasionally general weakness, headache, stomach pain, nausea, vomiting, diarrhea, and rash may occur.

Special instructions

During treatment, it is recommended to increase the amount of fluid consumed.

It is recommended to stop breastfeeding before using Ambroxol.

Interactions

Ambroxol, when used simultaneously with amoxicillin, cefuroxime, erythromycin, doxycycline, contributes to an increase in the concentration of these antibiotics in the lung tissue.

It is not recommended to use the drug simultaneously with drugs that exhibit antitussive activity (for example, containing codeine) due to difficulty in the discharge of sputum from the bronchi against the background of a decrease in cough.

Overdose

Not marked.

Storage conditions

In a dry place, protected from light, at a temperature of 15-25 °C.